Yale-led Technology Receives FDA Approval for Breast Cancer Treatment
May 07, 2026
May 07, 2026
NEW HAVEN, Connecticut, May 7 -- Yale University issued the following news:
* * *
Yale-led technology receives FDA approval for breast cancer treatment
The biotech company Arvinas was originally founded based on pioneering research from Yale chemist Craig Crews into PROTAC protein degraders.
By Meg Dalton
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research . . .
* * *
Yale-led technology receives FDA approval for breast cancer treatment
The biotech company Arvinas was originally founded based on pioneering research from Yale chemist Craig Crews into PROTAC protein degraders.
By Meg Dalton
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research . . .